A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
Conditions
Healthy Participants · Hemophilia A · Hemophilia B · Factor VII Deficiency
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
California Clinical Trials Medical Group (CCTMG), Glendale, California, United States
Children's Hospital Los Angeles, Los Angeles, California, United States
Rush University Medical Center, Chicago, Illinois, United States
LA Center for Bleeding and Clotting Disorders - Metairie, Metairie, Louisiana, United States
University of Michigan Hospitals - Michigan Medicine, Ann Arbor, Michigan, United States
Washington University School of Medicine, St Louis, Missouri, United States
Brody School of Medicine at East Carolina University, Greenville, North Carolina, United States
Penn State Milton S Hershey Medical Center Pediatrics, Hershey, Pennsylvania, United States
Perelman Center for Advanced Medicine (PCAM)- Penn Blood Disorders Program, Philadelphia, Pennsylvania, United States
McMaster University Medical Centre, Hamilton Health Sciences, Hamilton, Ontario, Canada